Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04121377
What this trial is testing

Feasibility of an Early Progressive Strength Exercise Programme for Acute Achilles Tendon Rupture

Who this might be right for
Achilles Tendon Rupture
Aalborg University Hospital 16
Testing effectiveness (Phase 2)Study completedNCT02831257
What this trial is testing

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

Who this might be right for
Neurofibromatosis 2Meningioma
Massachusetts General Hospital 18
Not applicableActive Not RecruitingNCT05327322
What this trial is testing

Functional Outcomes From Diets in Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
University of Alabama at Birmingham 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195399
What this trial is testing

A New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery

Who this might be right for
Desmoid FibromatosisRecurrent Desmoid FibromatosisUnresectable Desmoid Fibromatosis
Children's Oncology Group 31
Not applicableStudy completedNCT01049399
What this trial is testing

Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy
Noscira SA 146
Large-scale testing (Phase 3)Not Yet RecruitingNCT07503587
What this trial is testing

Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis

Who this might be right for
Progressive Pulmonary Fibrosis
Haisco Pharmaceutical Group Co., Ltd. 378
Not applicableUnknownNCT05562414
What this trial is testing

Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Chronic ProgressiveHigh-Intensity Interval TrainingMotor Symptoms
Klinik Valens 30
Not applicableUnknownNCT03201406
What this trial is testing

Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease

Who this might be right for
Diabetic NephropathiesLupus NephritisRapidly Progressive Glomerulonephritis+1 more
National Taiwan University Hospital 837
Large-scale testing (Phase 3)Study completedNCT07626892
What this trial is testing

Efficacy and Safety of 0.01%, 0.03%, and 0.05% Atropine Eye Drops in Reducing Myopia Progression

Who this might be right for
Myopia ProgressionAtropine
Khyber Medical College, Peshawar 95
Testing effectiveness (Phase 2)Ended earlyNCT00813592
What this trial is testing

Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma

Who this might be right for
Cancer
University of Utah 2
Not applicableLooking for participantsNCT05848271
What this trial is testing

Natural History Study of Patients with HPDL Mutations

Who this might be right for
Mitochondrial EncephalomyopathiesHereditary Spastic ParaplegiaSpastic Paraplegia+4 more
University of California, San Diego 50
Not applicableLooking for participantsNCT07461467
What this trial is testing

Effects of Continuous Monitoring and Progressive Regulation of Inflatable Laryngeal Mask Airway Cuff Pressure on Postoperative Pharyngolaryngeal Complications in Elderly Patients

Who this might be right for
Elderly (People Aged 65 or More)LMARandomized Controlled Trial+4 more
First Affiliated Hospital of Chongqing Medical University 146
Early research (Phase 1)Study completedNCT05101109
What this trial is testing

Study to Evaluate the Safety and Tolerability of ABL501, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL501 in Subjects With Any Progressive, Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
ABL Bio, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT02933801
What this trial is testing

ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.

Who this might be right for
Prostate Cancer MetastaticProstate Cancer
Swiss Cancer Institute 92
Testing effectiveness (Phase 2)Ended earlyNCT01555281
What this trial is testing

Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Swiss Cancer Institute 33
Not applicableStudy completedNCT00227409
What this trial is testing

Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency

Who this might be right for
Urologic Disease
Chang Gung Memorial Hospital
Testing effectiveness (Phase 2)Active Not RecruitingNCT06061809
What this trial is testing

N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
ImmunityBio, Inc. 34
Testing effectiveness (Phase 2)Study completedNCT00448409
What this trial is testing

Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 27
Not applicableUnknownNCT05496881
What this trial is testing

Exercise Effects in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive+2 more
University of Regina 69
Large-scale testing (Phase 3)Looking for participantsNCT05961644
What this trial is testing

Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).

Who this might be right for
Multiple Sclerosis, Secondary ProgressiveMultiple Sclerosis
Institute of Psychiatry and Neurology, Warsaw 188
Next Page